Casdin Capital’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
Casdin Capital's GH Position: Q3 2026 in Review
Casdin Capital held its Guardant Health (GH) position steady in Q3 2026 at 185,000 shares worth $33M. The position accounts for 1.44% of the portfolio, ranked #15.
Casdin Capital first reported a position in GH in Q4 2021 and has held it in 13 quarters since. The position peaked at $79M in Q4 2021. 666 funds tracked by Wall St. Rank hold GH as of Q3 2026.
- Casdin Capital held 185,000 shares of Guardant Health worth $33M as of Q3 2026.
- Casdin Capital left its Guardant Health share count unchanged in Q3 2026.
- Guardant Health made up 1.44% of Casdin Capital's portfolio in Q3 2026, its #15 holding.
- Casdin Capital first reported a position in Guardant Health in Q4 2021 and has held it in 13 quarters since.
- Casdin Capital's Guardant Health position peaked at $79M in Q4 2021.
- 666 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.
Based on Casdin Capital's 13F filing for Q3 2026, filed 16 Nov 2026.